Immunome

IMNMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.925 B

$25.75 +2.71%

Close of 22 Sept 2026

Revenue

$6.94M

#3225 by revenue

Earnings

-$212.4M

Loss-making

Shares outstanding

113,577,629

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#77MBX BiosciencesMBX$2.98B
#78Zai LabZLAB$2.96B
#79ImmunomeIMNM$2.92B
#80Vicore Pharma Holding ABVCRE$2.86B
#81PrecigenPGEN$2.82B

What if Immunome were worth as much as…

Open the what-if tool →

Gold $30.2T

$266,196.52

Per share 10,338× higher

Bitcoin $1.74T

$15,334.49

Per share 596× higher

Nvidia $5.52T

$48,563.85

Per share 1,886× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Immunome are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.